Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01429883

Enrollment

Registered

2011-09-07

Start date

2011-07-31

Completion date

2015-01-31

Last updated

2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achillodynia, Epikondylopathia Humeri /Radii, Fasciitis, Plantar, Periarthritis Calcarea

Brief summary

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Detailed description

Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

-Patients with: * Fascititis plantaris, * Achillodynie, * Periarthropathia humerosacpularis calcarea or * Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria

* Anticoagulation, * Sepsis

Countries

Switzerland

Outcome results